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Information This	section	was	published	as	Supporting	Information	alongside	following	publication:	Seel,	C.	J.;	Králıḱ,	A.;	Hacker,	M.;	Frank,	A.;	König,	B.;	Gulder,	T.,	Atom-Economic	Electron	Donors	for	Photobiocatalytic	Halogenations.	ChemCatChem	2018.	–	Published	by	Wiley-VCH	and	ChemPubSoc	Europe	Contributions	of	each	author	are	specified	throughout	the	document	by	each	subsection.	
	
1. General	Information	 1	
1.1 Analytical and Preparative Procedures 1	
1.2 Light Sources 2	
2. Cloning,	Protein	Production	and	Purification	 	 3	
2.1 Heterologous Production of CiVHPO 3	
2.2 Heterologous Production of AmVHPOII 4	
2.3 Comparison of AmVHPO and AmVHPOII 6	
2.4 Preparation of Lyophilized Lysate (AmVHPO) 6	
2.5 Specific Activities 7	
3. Quantitative	Assays	 8	
3.1 MCD Assay	 8	
3.2 Horseradish Peroxidase Assay for H2O2 Quantification (POD Assay)	 8	
3.3 Kinetics of H2O2 Generation in MES Buffer Using FMN as photocatalyst 9	
3.4 Kinetic Measurements of the O2-Consumption 10	
4. Photobiocatalytic	Reactions	 11	
4.1 Photochemical Set-Up 11	
4.2 General Procedure 11	
4.3 GC and HPLC Measurements 13	
4.4 Overview of the Halogenated Products and Retention Times 14	
4.5 Bromination of N,N-Dimethylaniline Using Different Methods for H2O2 Supply 16	
4.6 Investigations on Different Enzymes, Halides and Applicability of Lyophilized Lysate 17	
4.7 Optimization of Catalyst Loading and Investigations on the Inactivation of the Enzyme   19	
4.8 Comparative Reactions with H2O2 (1.1 eq.) 23	
4.9 Control Reactions Regarding FMN-Independent H2O2 Evolution 24	
4.10 Investigations on Decomposition of the Substrates due to Photooxidation 26	
4.11 Investigations on the Buffer Concentration 28	
Flavin	Properties	 29	
5.1 Degradation of the Enzyme by Excited FMN in High Catalyst Loadings	 29	
5.2 Self-Oxidation of FMN 29	
5.3 Absorption Spectra of FMN in Different Buffers 29	
Water-Splitting	Using	Au-TiO2	 30	
6.1 Evaluation of Different Light Sources for H2O2 Generation via Water Oxidation 30	
6.2 Kinetics of the H2O2 Evolution 31	
6.3 Comparison of the Activity of Different Forms of TiO2 32	
6.4 Water-Splitting Coupled to AmVHPO Catalyzed Bromination 34	
Synthesis	of	the	Halogenated	Reference	Material	 35	
7.1 General Procedure for the Synthesis of the Halogenated Products 35	
7.2 Synthesis of Ethyl 4-bromo-3,5-dimethyl-1H-pyrrole-2-carboxylate (2f) 35	
7.3 Up-Scaled Enzymatic Reaction on (E)-1,3-Dimethoxy-5-(4-methoxystyryl)benzene (1k) 35	
7.4 Preparation of (E)-2-Chloro-1,5-dimethoxy-3-(4-methoxystyryl)benzene (3d) 36	
References	 40	
NMR	Spectra	 41	
1 
 
1. General	Information	
Solvents used in reactions were p.a. grade. Solvents for chromatography were technical grade and distilled 
prior to use. Reactions were monitored by thin layer chromatography (TLC) carried out on Merck silica gel 
aluminum plates with F-254 indicator using UV light as the visualizing agent. Silica gel Merck 60 (particle 
size 0.63 – 0.2 mm) was used for flash column chromatography. Solvent mixtures are reported as 
volume/volume (v/v). NMR spectra were recorded on Bruker AV300, Bruker AV400 or Bruker AV500 
spectrometers. The spectra were calibrated using residual undeuterated solvents as internal references 
(CHCl3 @ 7.26 ppm, DMSO @ 2.50 and 3.33 1H NMR and CHCl3 @ 77.00 ppm, DMSO @ 39.52 13C NMR). 
The following abbreviations (or combinations thereof) are used to explain the multiplicities: s = singlet, d 
= doublet, dd = doublet of doublets, t = triplet, dt = doublet of triplets, q = quartet, m = multiplet, br = 
broad. In addition, the following abbreviations are used: EtOAc = ethyl acetate, MeCN = acetonitrile, rt = 
room temperature, sat = saturated, MES = 2-(N-morpholino)-ethanesulfonic acid, NaOAc = sodium 
acetate, Tris = tris(hydroxymethyl)aminomethane, MOPS = 3-(N-morpholino)propanesulfonic acid, HEPES 
= 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, EDTA = ethylenediaminetetraacetic acid, TFA = 
trifluoroacetic acid, MCD = monochlorodimedone, IPTG = isopropyl β-D-1-thiogalactopyranoside, Ni-NTA 
= nickel-nitrilotriacetic acid, LB = lysogeny broth,TB = terrific broth, FMN = favin mononucleotide, RFTA = 
riboflavin tetraacetate, PMSF = phenylmethyl-sulfonyl fluoride, SDS = sodium dodecyl sulfate, n.d. = not 
determined. . RFTA[1] and Au-TiO2[2] were prepared according to known literature procedures. The DA-64 
dye was purchased from Ark Pharm Inc. All other chemicals were purchased (Sigma Aldrich, Acros, or TCI) 
at the highest commercial quality and used without further purification or synthesized as described below. 
Vanadium-dependent bromoperoxidase from Corallina officinalis (CoVHPO), glucose oxidase from 
Aspergillus niger and horseradish peroxidase were purchased from Sigma-Aldrich. 
 
1.1 Analytical and Preparative Procedures 
 
Mass spectra (LC-ESI-MS) were determined on a Thermo LCQ fleet coupled with a Dionex UltiMate 3000 
HPLC. GC-MS measurements were conducted on a Finnigan MAT SSQ 7000 (MS-EI, 70 eV; CI, 100 eV). HR-
ESI-MS mass spectra were recorded on a Thermo LTQ FT Ultra coupled with a Dionex UltiMate 3000 HPLC 
system. Gas chromatography (GC) was performed on two different instruments. GC(1) measurements 
were carried out on a HP 6890 Series GC instrument (Agilent, equipped with a FID detector and a HP-5 
capillary column [length = 29.5 m]). Hydrogen was used as the carrier gas and the constant-flow mode 
(flow rate = 1.8 mL min–1) with a split ratio of 1:20. The following temperature-program was used: 60°C 
for 3 min, 15°C min-1 to 250°C in 12 min, and 250°C for 5 min. GC(2) measurements were carried out on a 
HP 6890 Series GC instrument (Agilent, equipped with a FID detector and a HP-5 capillary column [length 
= 30.0 m]). Helium was used as the carrier gas and the constant-flow mode (flow rate = 1.0 mL min–1) with 
a split ratio of 1:40. The following temperature-program was used: 40°C for 3 min, 15°C min-1 to 280°C in 
16 min, and 280°C for 5 min. Head-space CG measurements were performed on INFICON 3000 Micro GC 
equipped with MS-5A column using argon as a carrier gas. High performance liquid chromatography 
(HPLC) analysis was performed on a HITACHI Chromaster system employing the following conditions: 150 
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x 4 mm Eurospher II (KNAUER®), 100 Å, 5 µm, C18, 25°C, flow rate: 1.0 mL min-1, water (+0.01% 
TFA)/MeCN (+0.01% TFA) gradient: 90/10 → 0/100 in 13 min. For medium pressure liquid chromatography 
(MPLC) a Reveleris® X2 MPLC system (Grace) was used together with Reverleris® Reverse Phase (RP) C18 
columns (Grace) using UV-detection at 220 nm, 254 nm, and 280 nm. Protein concentrations were 
determined using a Nanodrop 2000c spectrophotometer (Thermo Scientific), ε(AmVHPO+His) = 65780 M-
1cm-1, MW = 73.13 kDa; ε(CiVCPO+His) = 91790 M-1cm-1, MW= 72.59 kDa. UV/Vis spectra were recorded 
on BioTek® Eon and Agilent Technologies Cary 100 spectrophotometers. In situ concentration of oxygen 
was monitored by PreSens Fibox 3 oxygen sensor. 
 
1.2 Light Sources 
 
Sample irradiation was performed using 455 nm (OSRAM Oslon SSL 80 royal-blue LEDs, λem = 455 nm (± 
15 nm), 3.5 V, 700 mA) or 375 nm (Avonec 370 – 380 nm UV-A LEDs, λmax = 375 nm, 3.5 – 4.5 V, 750 mA) 
LED light sources. 
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2. Cloning,	Protein	Production	and	Purification	(C. J. Seel, A. Frank)	
The heterologous expression and purification of the Acaryochloris marina vanadium-dependent 
haloperoxidase (AmVHPO) has been reported previously.[3] The protocol was slightly adjusted using Ni-
NTA beads (Jena Bioscience) instead of a Histrap column.  
 
2.1 Heterologous Production of CiVHPO (C. J. Seel) 
 
For recombinant production of the Curvularia inaequalis vanadium-dependent haloperoxidase (CiVHPO, 
Genbank accession number CAA59686), the codon-optimized synthetic gene (Eurofins) was introduced 
into a pETDuet-1 (Novagen) vector by restriction digest (PstI, NotI) and ligation. Successful insertion of the 
gene and the absence of undesired mutations were verified by Sanger sequencing (GATC). As a 
consequence of the cloning process, the VHPO open reading frame was modified by the addition of a N-
terminal hexahistidine sequence. 
 
 
Figure S1. a) Vector map of the pETDuet::civhpo construct. b) SDS-Page of the purification of CiVHPO; FT = flow-
through; P = pellet; W = wash; F1 – F6 = elution fractions; the corresponding molecular weights of the protein marker 
are stated in kilodaltons (kDa); size of CiVHPO+His approx. 73 kDa. 
 
The obtained pETDuet::civhpo expression vector was used to transform E. coli BL21 (DE3) cells for protein 
production. Recombinant cells were grown on LB agar plates and subsequently used for inoculation of TB 
liquid cultures. All media contained ampicillin as a selective antibiotic at a final concentration of 100 µg 
mL-1. Cells were grown in 1.5 – 3 liter expression cultures at 37°C while shaking at 150 – 180 rpm. At an 
optical density of 0.6, protein production was induced by the addition of IPTG to a final concentration of 
0.1 mM and cultures were incubated overnight at 16°C. Cells were harvested by centrifugation and 
washed with 0.9% NaCl solution. The cells were then resuspended in lysis buffer (10 mM imidazole, 50 
mM NaH2PO4, 300 mM NaCl, 10% glycerol) and PMSF (protease inhibitor), lysozyme and DNAse were 
a) b) 
 
4 
 
added. The suspension was sonicated on ice and centrifuged at 14,000 g for 30 min. Subsequently, the 
soluble fraction was incubated with Ni-NTA resin (Jena Bioscience, 1 mL per 1 L culture) and gently shaken 
on ice for 45 min. Thereafter, the resin-containing solution was transferred to a column and the flow-
through was eluted (gravity flow). After washing the bead bed with 20 mL of binding buffer (30 mM 
imidazole, 50 mM NaH2PO4, 300 mM NaCl, 10% glycerol), the His-tagged protein was eluted in fractions 
of 0.5 mL (500 mM imidazole, 50 mM NaH2PO4, 300 mM NaCl, 10% glycerol). Fractions of the highest 
apparent purity were pooled and then subjected to a buffer-exchange by the use of PD-10 desalting 
columns (GE Healthcare). The exchanged buffer was used for storage of the enzyme (50 mM Tris pH 7.0, 
100 µM Na3VO4). After concentration (if required), the enzyme was flash-frozen using liquid nitrogen and 
stored at -80°C until further use. 
 
Alternatively, a buffer containing 50 mM MES pH 6.0, 300 mM NaCl and 100 µM Na3VO4 was used in order 
to keep the pH of the reactions at pH 6, more accurately. The stability of AmVHPO in the MES storage 
buffer, however, was notably lower.  
 
2.2 Heterologous Production of AmVHPOII (C. J. Seel) 
 
The gene sequence of the isoenzyme AmVHPOII (Genbank accession number WP_012161787) was PCR-
amplified using genomic DNA from Acaryochloris marina (strain MBIC 11017) as a template. The sequence 
was then introduced into a pETDuet-1 (Novagen) vector by restriction digest (BamHI, PstI) and ligation. 
Successful insertion of the gene and the absence of undesired mutations were verified by Sanger 
sequencing (GATC). Analogous to the above described cloning strategy for CiVHPO, the protein was 
tagged N-terminal with a His6-tag. E. coli BL21 (DE3) was used as expression host. The heterologous 
 
  
Figure S2. a) Vector map of the pETDuet::amvhpoII construct. b) SDS-Page of the purification of AmVHPOII; S = 
supernatant; F1 –F5 = elution fractions; the corresponding molecular weights of the protein marker are stated in 
kilodaltons (kDa); size of AmVHPOII+His approx. 70 kDa. 
a) 
 
b) 
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production was carried out as described in 2.1, except for the utilization of LB media instead of TB media 
and the induction with 1 mM IPTG final concentration. The Ni-affinity purification was followed by size-
exclusion chromatography. The relatively late elution of the protein pointed to a smaller oligomeric state 
compared to the isoenzyme AmVHPO. For gel filtration a flow-rate of 1.0 – 1.6 mL min-1 in a single buffer 
(20 mM Tris pH 7.5, 100 mM NaCl, 0.001% NaN3) was used. For activity assays, the buffer was exchanged 
(to 50 mM MES pH 6.0, 100 µM Na3VO4) by the use of a PD-10 column. 
 
 
 
Figure S3. UV diagram of the size-exclusion chromatography of AmVHPOII using a Superdex S200 analytical gel 
filtration column (GE healthcare). The peak fraction of AmVHPOII (marked with a red star) eluted approx. 35 mL after 
the expected void volume of the column, suggesting the presence of either a dimer or a monomer. In comparison, 
the isoenzyme AmVHPO elutes shortly (approx. 10 mL) after the void volume and has been shown to form a 
homododecameric structure. The fractions were analyzed by SDS-Page; the corresponding molecular weights of the 
protein marker are stated in kilodaltons (kDa).  
 
Figure S4. MCD Assay (see in 3.1.) as a proof of ex vivo functionality of AmVHPOII. Bromination activity, but no 
chlorination activity was observed in this standard assay for VHPOs. It is worth mentioning, however, that the MCD 
assay is not a fully reliable indicator for chlorination activity as selective chloroperoxidases from Streptomyces, for 
example, do not promote the chlorination of MCD.[4] 
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2.3 Comparison of AmVHPO and AmVHPOII (C. J. Seel) 
 
 
Figure S5. a) Sequence alignment of the two isoenzymes AmVHPO and AmVHPOII from Acaryochloris marina. Active 
site residues are labeled with an asterix, intra- and intermolecular disulfide bonds present in AmVHPO are most likely 
not formed in AmVHPOII (no respective cysteine residues are present). Typical conserved domains in vanadium-
dependent haloperoxidases[5] are labeled with a green and blue box. Interestingly, the conserved serine (green box) 
is replaced by an alanine in both VHPOs from Acaryochloris marina. b) Superposition of the crystal structure of 
AmVHPO (PDB ID: 5LPC, cyan) and a homology model for AmVHPOII generated by MODELLER[6] (green). 
 
In addition to other striking similarities to algal VHPOs, a second isoenzyme is also present in the A. marina 
genome (a set of two VHPOs was also found in brown algae Ascophyllum nodosum and red seaweed 
Corallina officinalis and Corallina pilulifera, respectively). The two isoenzymes are not embedded in a 
biosynthetic gene cluster, the physiological function and natural substrate(s) thus remain unclear. 
Interestingly, the isoenzyme (AmVHPOII) seems to possess a different overall structure, lacking the 
characteristic disulfide bonds found in AmVHPO (43% sequence identity to AmVHPO; e-value 7e-146). We 
heterologously produced AmVHPOII and investigated its halide specificity. Just like AmVHPO, no 
chlorination activity, only bromination activity was detected in the MCD assay (Figure S4). Furthermore, 
we found — based on a comparably high retention time in size exclusion chromatography — that 
AmVHPOII most likely does not form a homododecamer like AmVHPO, but occurs rather in a dimeric or 
monomeric state. 
7 
 
2.4 Preparation of Lyophilized Lysate (AmVHPO) (C. J. Seel) 
 
Lyophilized lysate was obtained from 7.4 g cell pellet which was resuspended in 80 mL lysis buffer (10 mM 
imidazole, 50 mM NaH2PO4, 300 mM NaCl). After sonication and centrifugation, the supernatant was 
subjected to a preliminary purification step (the supernatant was heated to 65°C for 30 min, followed by 
centrifugation at 40,000 g for 30 min). From the resulting supernatant, 15 mL were gathered and freeze-
dried. Aliquots of 10 mg of the residual powder were used for the enzymatic reactions. 
 
 
2.5 Specific Activities (C. J. Seel) 
 
Table S1. Specific activities of the employed protein from different purification batches determined by the MCD 
Assay (see in 3.1). 
c [mg mL-1] Aspec (Br) [U mg-1] 
AmVHPO 
3.50  6.13 
1.46 3.55 
1.47 n.d. 
3.00 6.41 
2.20 n.d. 
1.50  32.54 
1.30 7.69 
4.50 39.51 
2.90 31.14 
1.62 2.71 
1.71 3.07 
CiVHPO 
0.62 6.43 
AmVHPOII 
0.90 11.7 
 
The specific activity of AmVHPO and AmVHPOII were determined at pH 6.0 (MES buffer), the specific 
activity of CiVHPO at pH 5.0 (MES buffer). 
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3. Quantitative	Assays	(C. J. Seel, A. Králík)	
 
3.1 MCD Assay[7] (C. J. Seel) 
 
 
 
A 1 mM stock solution of MCD was prepared in 2 M aqueous NaOAc. Assays were performed in triplicate 
in 96-well polystyrene microplates (Brand® F-bottom, UV-transparent, pureGrade™). For initiation, H2O2 
(30 µL, 10 mM final) was added to the assay mixture (270 µL), containing MES buffer (50 mM, pH 6.0), 
MCD (50 µM), KBr (200 mM) or KCl (200 mM), Na3VO4 (1 µM) and VHPO (1 µL of the purification batch or 
dilutions thereof) in an overall volume of 300 µL. The decrease in absorbance at 290 nm was monitored 
continually while keeping the temperature at 30°C and mixing at 410 rpm. The specific activity of each 
purification batch was calculated from the decrease in absorbance A290 using the equation:  
 
specific activity [µmol MCD/(mg enzyme · min)] =	  ΔA290[s-1] · 60 · Vassay[mL]
εMCD · d · Venzyme[mL] · cenzyme	[mg mL-1]    
with εMCD = 19.9 mL µmol-1 cm-1 and d = 0.91 cm 
 
 
 
3.2 Horseradish Peroxidase Assay for H2O2 Quantification (POD Assay) (C. J. Seel, A. Králík) 
 
In order to quantify H2O2 concentrations, a photometric assay based on the dye DA-64 was applied. In the 
presence of hydrogen peroxide, the colorless dye is converted to Bindschedler's Green (λmax = 727 nm) in 
a reaction catalyzed by the enzyme horseradish peroxidase (POD).[8] 
A freshly pre-mixed working solution (250 µL; DA-64 1 mM (higher H2O2 concentrations) or 0.1 mM (lower 
H2O2 concentrations); POD 0.4 U mL-1 (approx. 0.04 U mL-1 for higher H2O2 concentrations); MES buffer 
pH 6.0, 50 mM) was added to the hydrogen-peroxide-containing probe or dilutions thereof (250 µL). The 
resulting assay solution was then incubated at 37°C for 30 min, and absorbance of the solution at 727 nm 
was recorded. 
For quantification, a calibration curve was established by conducting the assay described above with a 
dilution series of defined concentrations of H2O2 (Figure S6). 
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Figure S6. Calibration curve for a quantification of H2O2 concentrations using the POD enzymatic assay. a) 
Calibration for lower concentrations ranging from 0–40 µM (using 0.1 mM solution of DA-64). b) Calibration for 
higher concentrations ranging from 50–500 µM (using 1 mM solution of DA-64). 
 
3.3 Kinetics of H2O2 Generation in MES Buffer Using FMN as Photocatalyst (A. Králík) 
The reaction setup analogous to previously described photobiocatalytic reactions was used (see Section 
4.2). An aqueous solution (1.6 mL) containing FMN (37.15 µM, corresponds to 0.5 mol% with regard to 
the substrate as described in Section 4.2) and MES buffer (100 mM, pH 6.0) in an open 5 mL crimp-top 
vial was irradiated with 455 nm LED for a selected amount of time. Afterwards, the reaction mixture was 
diluted 50-times and analyzed by the POD assay as described in Section 3.2. In parallel, we investigated if 
the presence of KBr influences the FMN-mediated photocatalysis (the kinetic experiment was performed 
as described above without KBr). No difference in the hydrogen-peroxide-production rate was observed. 
 
Figure S7. Kinetic of the H2O2 evolution by FMN in a MES-buffered solution. (cf. Figure 2, main text). 
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3.4 Kinetic Measurements of the O2-Consumption (A. Králík) 
To confirm the crucial role of oxygen in flavin-catalyzed hydrogen-peroxide evolution, the change of the 
oxygen concentration in an aqueous FMN solution under irradiation with blue light in a sealed vial was 
monitored with an oxygen probe. 
A screw-top vial (4.5-cm-high) equipped with a phosphorescent dot for oxygen sensing and a stirring bar 
filled to the top with an aqueous solution of FMN (37.15 µM ≙ 0.5 mol%; 371.5 µM ≙ 5 mol%; 743 µM ≙ 
10 mol%; 2.23 mM ≙ 30 mol%) and MES buffer (100 mM, pH 6) was placed on a magnetic stirrer above a 
single 455 nm LED equipped with a glass rod. The solution was constantly stirred and after one minute of 
oxygen-concentration measurement, the light was switched on (black arrow in Figure S8) and the sample 
was irradiated for 4 min. 
The results of these experiments can be found in Figure S8 confirming that oxygen is consumed during 
this reaction. The kinetic profiles were measured for all FMN concentrations and showed comparable 
behavior. The calculated light-penetration depth for a 37.15 µM (0.5 mol%) solution of FMN in 100 mM 
MES buffer at 455 nm is 2.66 cm. These findings suggest that all light has been absorbed, indicating that 
the rate-determining factor of this reaction under given conditions is the intensity of the used light source. 
 
Figure S8. Change in oxygen concentration in an aqueous solution containing MES buffer and different 
concentrations of FMN under blue-light irradiation.  
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4. 	Photobiocatalytic	Reactions	
 
4.1 Photochemical Set-Up 
                       
 
Figure S9. a) Image of the photocatalytic set-up combined with a horizontal shaker. b) Schematic image of the set-
up including cooling block and LED array.[9]  
 
FMN-catalyzed photobiocatalytic reactions were performed using 455 nm LEDs. Reaction vials (5 mL 
crimp-cap vials with loosely attached cap to allow oxygen supply) were illuminated from the bottom and 
cooled from the side using a custom-made aluminum cooling block connected to cooling-water supply. A 
horizontal shaker was placed below the LED array to allow for homogeneous mixing without mechanically 
disrupting the enzyme. 
 
4.2 General Procedure (C. J. Seel, M. Hacker) 
The enzymatic reactions were performed as described below and terminated by the addition of sat. NaCl 
solution. EtOAc (300 µL) and 100 µL of a stock solution of internal standard (0.06 M phenol for HPLC; 0.06 
M dodecane or toluene for GC analysis) were added, the mixture was extracted with EtOAc and the 
organic phase was analyzed (dilution 1/10 for HPLC analysis). For NMR analysis, the mixture was extracted 
with EtOAc (3 × 2 mL), the organic extract was dried over MgSO4, filtered and concentrated under reduced 
pressure. Subsequently, the internal standard (1,4-dibromobenzene) was added to the crude material and 
spectra were recorded in CDCl3. The reaction scale was adjusted for the determination of the conversion 
by NMR: 1j (25 µmol); 1k (12 µmol for bromination, 7.5 µmol for chlorination (0.5 mol% FMN), 3.7 µmol 
for chlorination (H2O2)) and 1m (23 µmol).    
 
Comparative Reactions with H2O2 (1.1 eq.) 
The reaction mixture containing substrate (7.43 mM; 11.89 µmol), KBr (1.1 eq; 8.13 mM or 2.2 eq; 
16.26 mM), MES pH 6.0 (50 mM), Na3VO4 (187.5 µM), H2O2 (1.1 eq; 8.13 mM or 2.2 eq; 16.26 mM) and 
VHPO (300 µL, concentrations indicated) in MeCN/H2O (1/1; total volume of 1.6 mL) was heated to 30°C 
and mixed at 300 rpm for 16 h. 
 
 
 
a) b) 
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Reactions with 0.5 mol% FMN in MES buffer 
The reaction mixture in MeCN/H2O (1/1; total volume of 1.6 mL) containing FMN (37.15 µM ≙ 0.5 mol%), 
substrate (7.43 mM; 11.89 µmol), KBr (1.1 eq; 8.13 mM), MES pH 6.0 (100 mM), Na3VO4 (187.5 µM) and 
VHPO (300 µL, concentrations indicated) was irradiated for 16 h at rt. 
 
Reactions with 10 – 30 mol% FMN, 1.1 eq. KBr in MES buffer 
Aliquots of a stock solution of FMN in water (11.89 mM; 100 µL aliquot ≙ 10 mol% etc.) were added to an 
aqueous mixture (total volume of 1.45 mL) containing MeCN (800 µL), substrate (11.89 µmol), KBr (1.1 
eq; 8.98 mM), MES pH 6.0 (110.6 mM), Na3VO4 (207.3 µM) and VHPO (300 µL, concentrations indicated).  
 
Reactions with 10 – 30 mol% FMN, 2.2 eq. KBr in MES buffer 
Aliquots of a stock solution of FMN in water (11.89 mM; 100 µL aliquot ≙ 10 mol% etc.) were added to an 
aqueous mixture (total volume of 1.46 mL) containing MeCN (800 µL), substrate (11.89 µmol), KBr (2.2 
eq; 17.81 mM), MES pH 6.0 (109.5 mM), Na3VO4 (205.5 µM) and VHPO (300 µL, concentrations indicated). 
 
 
Method A: Addition of 10 – 30 mol% FMN and irradiation for 1 – 2 h in the presence of enzyme (300 µL), 
total reaction time 16 – 72h. 
 
Method B: Addition of 15 mol% FMN and irradiation for 30 min; after addition of enzyme (150 µL) 30 min 
without irradiation; addition of 15 mol% FMN and irradiation for 30 min; subsequently addition of enzyme 
(150 µL), total reaction time 16 h. 
 
Method C: Addition of 5 mol% FMN every 30 min (3 h irradiation), total reaction time 16 h. 
 
Method D: Addition of 30 mol% FMN (1 h irradiation), then addition of AmVHPO, total reaction time 16 h. 
 
Method E: Addition of 15 mol% FMN and irradiation for 30 min; addition of 15 mol% FMN and irradiation 
for 30 min; subsequently addition of the substrate and enzyme (300 µL).    
 
Method F: Addition of 15 mol% FMN and irradiation for 30 min; then addition of the substrate and enzyme 
(300 µL). 
 
Method G (optimized procedure used for oxidation-sensitive substrates): Irradiation of 15 mol% FMN in 
MES-buffered solution for 15 min; addition of 15 mol% FMN and irradiation for further 15 min; 
subsequently addition of the substrate, enzyme (300 µL) and all other components of the mixture. 
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4.3 GC and HPLC Measurements (C. J. Seel. A. Králík) 
 
 
 
 
Figure S10. Example of a GC chromatogram of the enzymatic N,N-dimethylanilin (1c) bromination. The chemical 
structures of o-2c, p-2c and o,p-di-2c were confirmed by authentic references. Toluene was used as the internal 
standard. The formation of the dibrominated product o,o-di-2c was not observed. 
 
Figure S11. Example of a calibration curve using brominated reference material.  
 
0 2 4 6 8
0
2
4
6
y = 0.9527x
R² = 0.999
A (compound) / A (std)
n 
(c
om
po
un
d)
 / 
n 
(s
td
)
t [min] 
FI
D 
co
un
t 
internal standard 
1c 
o-2c 
p-2c      o,p-di-2c                
 
14 
 
4.4 Overview of the Halogenated Products and Retention Times (C. J. Seel) 
 
GC(1) measurements were carried out on a HP 6890 Series GC instrument (Agilent, equipped with a FID 
detector and a HP-5 capillary column [length = 29.5 m]). Hydrogen was used as the carrier gas and the 
constant-flow mode (flow rate = 1.8 mL min–1) with a split ratio of 1:20. The following temperature-
program was used: 60°C for 3 min, 15°C min-1 to 250°C in 12 min, and 250°C for 5 min. Dodecane was used 
as internal standard. GC(2) measurements were carried out on a HP 6890 Series GC instrument (Agilent, 
equipped with a FID detector and a HP-5 capillary column [length = 30.0 m]). Helium was used as the 
carrier gas and the constant-flow mode (flow rate = 1.0 mL min–1) with a split ratio of 1:40. The following 
temperature-program was used: 40°C for 3 min, 15°C min-1 to 280°C in 16 min, and 280°C for 5 min.  
Dodecane was used as internal standard. GC(3) measurements were carried out on a HP 6890 Series GC 
instrument (Agilent, equipped with a FID detector and a HP-5 capillary column [length = 30.0 m]). Helium 
was used as the carrier gas and the constant-flow mode (flow rate = 1.0 mL min–1) with a split ratio of 
1:40. The following temperature-program was used: 40°C for 3 min, 15°C min-1 to 280°C in 16 min, and 
280°C for 5 min.  Toluene was used as internal standard.  High performance liquid chromatography (HPLC) 
analysis was performed on a HITACHI Chromaster system employing the following conditions: 150 x 4 
mm Eurospher II (KNAUER®), 100 Å, 5 µm, C18, 25°C, flow rate: 1.0 mL min-1, water (+0.01% TFA)/MeCN 
(+0.01% TFA) gradient: 90/10 → 0/100 in 13 min and phenol as the internal standard. 
 
   
  
HPLC:     10.3 min 10.8 min 12.1 min   
  
  
 
HPLC:     10.2 min 11.9 min 12.7 min 10.7 min (<5 %) 
     
GC(3):    8.3 min 10.0 min 11.4 min 12.5 min not observed 
   
  
HPLC:    8.9 min 11.3 min 13.5 min   
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HPLC:    10.2 min 12.2 min 13.7 min   
  
   
HPLC:  10.1 min 11.9 min    
 
  
  
GC(2):   14.8 min 17.2 min 19.3 min   
    
GC(1):     8.6 min 11.2 min 9.8 min 12.0 min 
 
 
  
GC(1):     9.0 min 13.8 min 14.9 min  
  
 
 
NMR:    6.22 (s, 1H) 7.47 (m, 1H)   
    
NMR:   6.65 (d, 2H) 6.42 (d, 2H) 6.70 (s, 2H) <5% in all cases not observed 
Figure S12. Substrates and brominated products. The retention times (GC) and selected signals for determination 
of the conversion by NMR are shown below. 
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HPLC:   10.3 min 10.6 min not observed   
    
 
HPLC:   10.2 min 11.0 min not observed not observed 
           
GC(1):    5.0 min 6.9 min 7.8 min not observed not observed 
Figure S13. Substrates and chlorinated products. The retention times (HPLC or GC) are shown below. 
 
   
 
NMR:   7.47-7.43 (m, 2H) 7.41 (d, 1H) not observed not observed 
  
 
 
NMR:    6.22 (s, 1H) 7.47 (m, 1H)   
Figure S14. Substrates and chlorinated products. The signals for determination of the conversion by NMR are shown 
below. 
 
4.5 Bromination of N,N-Dimethylaniline Using Different Methods for H2O2 Supply  (C. J. Seel) 
Table S2. Enzymatic bromination of N,N-dimethyaniline (1c) as a model reaction to investigate the impact of 
different H2O2-supply methods. 
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Entry H2O2 supply Conversion Ratio (o-2c : p-2c : o,p-di-2c) 
1 Syringe pump 81% 24 : 70 : 6 
2 GOx (12 U) 10% 13 : 87 : 0 
3 GOx (24 U) 18% 13 : 87 : 0 
4 Urea H2O2 64% 16 : 84 : 0 
5 H2O2 (1.1 eq.) 84% 19 : 81 : 0 
6a H2O2 (2.2 eq.) 100% 14 : 50 : 36 
7 tBuOH one batch H2O2 69% 25 : 63: 12 
AmVHPO (3.0 mg mL-1; 300 µL); reaction time 72 h; the formation of o,o-di-2c was not  
observed. aKBr (2.2 eq.) 
 
Procedure 
The reactions were performed as described in 4.2 using AmVHPO (300 µL ≙ ca. 6 U) pre-incubated with 
Na3VO4 (30 mM; 300 µL). The total reaction volume was 1.6 mL (MeCN/H2O : 1/1; for Entry 7 tBuOH/H2O : 
1/1). The different supply methods were carried out as follows: slow supply with syringe pump (1.1 eq. 
H2O2 at a flow-rate of 0.72 µL/min, total time 3h); slow release from urea H2O2 (1.1 eq.; 100 mM stock 
solution in water, 130 µL) or addition of D-glucose (212 µL; 10 mg mL-1; 1.0 eq.) and glucose oxidase (GOx 
was pre-weighed and calculated according to the U mg-1 declaration of the supplier). 
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4.6 Investigations on Different Enzymes, Halides and Applicability of Lyophilized Lysate 
(C. J. Seel) 
Table S3. Ratios and conversions of the enzymatic bromination of 1,3,5-trimethoxybenzene (1a). 
 
 
Entry Enzyme H2O2 source Conversion Ratio (2a : di-2a) 
1a CiVCPO  FMN/455 nm 87% 100 : 0 
2 CiVCPO  H2O2 (1.1 eq.) 40% 77 : 23 
3b AmVHPO  H2O2 (1.1 eq.) 94% 92 : 8 
4 AmVHPO  H2O2 (1.1 eq.) 75% 99 : 1 
5c AmVHPO (lysate) H2O2 (1.1 eq.) 96% 94 : 6 
AmVHPO (1.46 mg mL-1; 300 µL); CiVHPO (0.62 mg mL-1; 300 µL).aFMN (30 mol%); method A; baddition  
of 30 mol% FMN to the reaction mixture, no irradiation and addition of H2O2 as oxidant; clyophillized 
 lysate (10 mg).  
 
 
The control reaction (entry 3) indicated that the presence of FMN in the absence of light does not 
inactivate the enzyme. 
 
 
 
Table S4. Ratios and conversions of the enzymatic halogenation of 1,3-dimethoxybenzene (1b). 
 
Entry Enzyme Halogen Source Conversion Ratio (2b : di-2b : regio-2b) 
1 CiVCPO  KBr 45% 100 : 0 : 0 
2 AmVHPO (lysate) KBr 73% 98 : 2 : 0 
 CiVCPO (0.62 mg mL-1; 300 µL); lyophillized lysate (10 mg). 
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Table S5. Ratios and conversions of the enzymatic halogenation of 2,6-dimethoxypyridine (1e). 
 
 
 
Entry Enzyme Halogen/H2O2 Source Conversion Ratio (2e : di-2e) 
1a AmVHPOII  KBr; H2O2 (1.1 eq.) 8% 100 : 0 
2b CiVCPO  KBr; H2O2 (1.1 eq.) 31% 100 : 0 
3a CiVCPO  KBr; H2O2 (1.1 eq.) 38% 100 : 0 
4a CiVCPO  KBr; FMN (5 mol%)/455 nm 11% 100 : 0 
5a CiVCPO  KBr; FMN (10 mol%)/455 nm     – – 
6b CiVCPO  KCl; H2O2 (1.1 eq.) trace <5 : 0 
7 AmVHPO (lysate) KBr; H2O2 (1.1 eq.) 14% – 
8 AmVHPO (lysate) KI; H2O2 (1.1 eq.) – – 
9a AmVHPO  KI; H2O2 (1.1 eq.) – – 
AmVHPOII (0.9 mg mL-1); CiVCPO (0.62 mg mL-1); AmVHPO (4.5 mg mL-1); lyophillized lysate (10 mg); a300 µL of 
enzyme; b100 µL of enzyme; entries 5 and 6: method A (1 h irradiation); total reaction time 16 h.  
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4.7 Optimization of Catalyst Loading and Investigations on the Inactivation of the Enzyme 
(C. J. Seel) 
Table S6. Optimization of the Reaction conditions. 
 
 
Entry H2O2-source Conditions Conversion Ratio (2e : di-2e) 
1a RFTA (30 mol%)/455 nm method C (3 h) 2% 100 : 0 
2a FMN (30 mol%)/455 nm method C (3 h) 4% 100 : 0 
3a H2O2 (1.1 eq.) 16 h, 30°C 53% 100 : 0 
4a RFTA (30 mol%)/455 nm method A (1 h) 1% 100 : 0 
5a FMN (30 mol%)/455 nm method A (1 h) 1% 100 : 0 
6a H2O2 (1.1 eq.) 16 h, 30°C 36% 100 : 0 
7a FMN (30 mol%)/455 nm method D (1 h) 28% 100 : 0 
8a RFTA (30 mol%)/455 nm method D (1 h),  23% 100 : 0 
9a H2O2 (1.1 eq.) 16 h, 30°C 57% 100 : 0 
10b H2O2 (1.1 eq.) irradiation of AmVHPO for 1 h, 
then addition of H2O2 
64% 100 : 0 
11b H2O2 (1.1 eq.) 16 h, 30°C 45% 100 : 0 
12b,c FMN (30 mol%)/455 nm  irradiation in the presence of 
AmVHPO (16 h); Brj35® 
1% 100 : 0 
13b,c H2O2 (1.1 eq.) 16 h, 30°C, Brj35® 49% 100 : 0 
aAmVHPO (1.50 mg mL-1; 300 µL); bAmVHPO (2.90 mg mL-1; 300 µL); cBrj35®(11.89 µmol; 14.45 mg; 1.1 eq.) as  
stabilizing additive for the enzyme. 
 
The control reaction (Entry 10) indicated that irradiation of the enzyme in the absence of FMN does not 
inactivate the enzyme. 
H2O2 (1.1 eq) is listed several times, because a control experiment was run in parallel for each set of 
experiments (indicated by the lines within the table). 
We started our investigations with a catalyst loading of 10 to 30 mol% FMN and reached complete 
conversion in the enzymatic bromination of 1,3,5-trimethoxybenzene (1a) using AmVHPO (Table S7, entry 
6). When turning to other (hetero-)aromatic substrates, however, the conversion dropped dramatically 
(Table S6, entry 4 and 5). We closely investigated the factors leading to this diminished conversion. A 
protocol, where H2O2 was pre-generated by irradiating FMN and subsequently adding the enzyme, lead 
to an improved turnover (Table S6, entry 7). Neither irradiation of the enzyme followed by addition of 
H2O2 (Table S6, entry 10) nor the presence of FMN without irradiation (Table S3, entry 3) influenced the 
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enzyme's activity indicating the high oxidative reactivity of excited FMN accounts for the inactivation of 
the enzyme. 
Intrigued by the observed incomplete turnover of 2,6-dimethoxypyridine (1e), we further investigated the 
enzymatic bromination over time and observed a fast initial rate for both substrates, the electron-rich 1a 
and the less electron-rich 1e (Figure S15). The fast initial rate of the enzymatic bromination of 1e, 
however, slows down after 30 min and a conversion of approximately 35% is not exceeded even after 16 h 
(neither for direct addition of the oxidant nor for in situ H2O2 generation). Both VHPOs, CiVHPO and 
AmVHPOII showed the same incomplete turnover of 1e as observed for AmVHPO (Table S5). Additional 
experiments with AmVHPO on 1e were performed, during which a second aliquot of enzyme was added 
after 30 min (conversion 34%), or 10% of product 2e were included in the reaction mixture right from the 
start (conversion 38%) to analyze whether product inhibition or equilibrium formation accounts for the 
stagnation of the conversion. These experiments, however, did not show significantly improved 
conversion compared to a reaction time of 30 min and addition of the enzyme in the beginning (33%). 
These results again address the so far unanswered question of the nature of the electrophilic halogenating 
species generated by VHPOs. Early work by Butler and co-workers[10] suggested substrate binding rather 
than freely diffusible oxidized bromine species based on fluorescence quenching as well as based on 
competitive kinetic experiments. To date, no VHPO crystal structure in complex with a substrate has been 
reported and the selectivity of VHPOs is still under debate. 
 
Figure S15. Kinetic monitoring of enzymatic brominations of 2,6-dimethoxypyridine (1e) and 1,3,5-trimethoxy-
benzene (1a). Individual reactions were run in parallel and quenched for analysis after a certain time. The total 
reaction time for addition of H2O2 in one batch was 4 h and for in situ H2O2 generation (0.5 mol% FMN) 16 h. The 
enzymatic reactions were performed using AmVHPO (1.47 mg mL-1; 300 µL). 
 
The productivity of an enzyme can be directly compared when calculating the turnover number and 
turnover frequency: 
turnover number (TN)	= mol (product)
mol (catalyst)  [mol·mol-1]                                   turnover frequency (TF)	=	 TNtime  [h-1] 
 
0 50 100 150 200
0
50
100
400 600 800 1000
H2O2 (1.1 eq.)
H2O2 (1.1 eq.) FMN (0.5 mol%)
FMN (0.5 mol%)
Time [min]
Co
nv
er
sio
n 
[%
]
 
 
22 
 
For substrate 1a a conversion of 93% (H2O2 addition in one batch) after 5 min was observed, this 
corresponds to a TN of 1833 and TF of 21996 h-1. The TN (631) and TF (7572 h-1) for substrate 1e is 
significantly lower (32% conversion after 5 min), indicating that the electronic properties of the substrate 
predominantly influence the TN. The turnover for the photobiocatalytic protocol is reduced due to the 
slow release of H2O2, the maximal productivity of the enzyme can thus not be deduced from these 
experiments.  
  
Table S7. Investigations on the applicability of FMN and RFTA using 1,3,5-trimethoxybenzene (1a) as a substrate.  
 
The irradiation time is given in brackets. aAmVHPO (2.2 mg mL-1; 300 µL); bno addition of 
enzyme; cAmVHPO (3.5 mg mL-1; 300 µL); d2.2 eq. KBr; eaddition of FMN (10 mol%), 1h 
irradiation then 16 h at rt without irradiation followed by addition of FMN (10 mol%), 1h 
irradiation and another 16 h at rt. 
 
 
Entry 1 shows that the presence of enzyme is essential for a successful halogenation. 
As it can be seen from entries 6 and 7, the special set-up with horizontal shaker (shaking 300 rpm) is 
superior to mechanical stirring of the enzyme-containing mixture. 
  
Entry  RFTA (mol%)  Time  Conversion  Ratio (2a : di-2a)  
1b  20  72 h, method A (2h) –  –  
2c H2O2 (1.1 eq.)  72 h    34% 66 : 35 
3c 10 16 h, method A (1h) 29% 100 : 0 
4c,e 20 48 h  48% 100 : 0 
Entry  FMN (mol%)  Time Conversion  Ratio (2a : di-2a) 
5c H2O2 (1.1 eq.)  16 h 71% 75 : 25 
6c 10 16 h, method A (1h); 
shaking 300 rpm 
93% 100 : 0 
7c 10 16 h, method A (1h); 
stirring 
79% 100 : 0 
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Table S8. Ratios and conversions of the enzymatic halogenation of 1,3-dimethoxybenzene (1b). 
 
Entry Time RFTA (mol%) Conversion Ratio (2b : di-2b : regio-2b) 
1  16 h H2O2 (1.1 eq.)  25% 92 : 8 : 0 
2a 16 h 10 9% 100 : 0 : 0 
Entry Time FMN (mol%) Conversion Ratio (2b : di-2b : regio-2b) 
3 16 h H2O2 (1.1 eq.)  75% 98 : 2 : 0 
4a 16 h 20 26% 98 : 2 : 0 
5a,b 16 h 20 26% 99 : 1 : 0 
amethod A, irradiation for 1 h; AmVHPO (300 µL, 3.5 mg mL-1); b2.2 eq. KBr. 
 
Table S9. Influence of the FMN concentration investigated for the photo-enzymatic bromination of thymol (1h). 
 
 
Entry Time FMN (mol%) Conversion Ratio (p-2h : o-2h : di-2h) 
1a 16 h 0.5 88% 88 : 10 : 2 
2b 16 h 1 29% 88 : 11 : 1 
3b 16 h 5 10% 88 : 12 : 0 
4c 16 h 10 17% 53 : 47 : 0 
5d 16 h 30 83% 88 : 10 : 2 
6e 16 h 30 73% 88 : 11 : 1 
7 16 h H2O2 (1.1 eq.) 84% 87 : 11 : 2 
aIrradiation for 16 h; bmethod A, irradiation for 2 h; cMES/MeCN (9/1) ; dmethod B; emethod D; 
AmVHPO (300 µL; 1.46 mg mL-1). 
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4.8 Comparative Reactions with H2O2 (1.1 eq.) (C. J. Seel) 
 
Scheme S1. Comparative enzymatic brominations with direct addition of the oxidant in one batch (1.1 eq. H2O2). 
Reactions contained MES buffer (100 mM, pH 6.0), [substrate] = 7.43 mM, [H2O2] = 8.13 mM, [AmVHPO] = 3.77 µM 
(1.47 mg mL-1; 300 µL), [KBr] = 8.13 mM, [Na3VO4] = 187.5 µM and were run at rt. aAmVHPO (1.46 mg mL-1; 300 µL). 
Conversions and ratios were determined by GC, HPLC or NMR. The respective major mono-brominated products are 
depicted. 
 
 
Scheme S2. Comparative enzymatic chlorinations with direct addition of the oxidant in one batch (1.1 eq. H2O2). 
Reactions contained MES buffer (100 mM, pH 5.0), [substrate] = 7.43 mM, [H2O2] = 8.13 mM, [CiVHPO] = 1.60 µM 
(0.62 mg mL-1; 300 µL), [KCl] = 8.13 mM, [Na3VO4] = 187.5 µM and were run at rt. Conversions and ratios were 
determined by GC, HPLC or NMR. The respective major mono-chlorinated products are depicted.  
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4.9 Control Reactions Regarding FMN-Independent H2O2 Evolution (C. J. Seel. A. Králík) 
Table S10. Control reactions without photocatalyst, enzyme, or H2O2, and dark reaction in MES buffer. 
Entry Substrate Conditions Conversion Ratio (mono : di) 
1 
 
no FMN 60%  100 : 0 
2 no AmVHPO <5% – 
3 
 
no FMN <5% – 
4 no AmVHPO <5% – 
5 
 
no FMN 12% 100 : 0 
6 no AmVHPO 0% – 
7 
 
dark reaction FMN, AmVHPO 0% – 
8  AmVHPO, no H2O2 0% – 
9 H2O2 100%  96 : 4 
  AmVHPO (300 µL; 1.71 mg mL-1); FMN 0.5 mol%; irradiation for 16 h. 
 
Figure S16. Color changes of the irradiated reaction mixtures after 16 h; the numbering corresponds to the entries 
of table S10. FMN-containing mixtures show photo-bleaching of the catalyst (entries 2,4 and 6). A slight yellow 
discoloration was observed for substrate-containing mixtures (entries 1,3 and 5). 
 
 
Table S11. Control reactions using 1,3,5-trimethoxybenzene (1a) as a substrate in the absence of photocatalyst in 
phosphate buffer. 
Entry Light KBr (8.13 mM) Vanadate (187.5 µM) Conversion 
1 455 nm + + decomp. 
2 – + + 0 % 
3 455 nm – + decomp. 
4 455 nm + – decomp. 
5 455 nm – – decomp. 
trimethoxybenzene (7.43 mM); AmVHPO (80 µL; 1.62 mg mL-1); overall volume 1.6 mL; 
O2 atmosphere; irradiation for 22 h. 
 
Entries 1, 3, 4, 5 showed an overall GC yield below 5%. This suggests an oxidative decomposition of 1,3,5-
trimethoxybenzene (1a) upon irradiation, 1a likely serves as a source of electrons for the formation of 
1 2 3 4 5 6 
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hydrogen peroxide. The lack of hydrogen peroxide in entries 1, and 3 of table S13 suggests decomposition 
of H2O2 under the given conditions. 
 
Figure S17. Color change of 1,3,5-trimethoxybenzene (1a) solutions after 22 hours of irradiation with blue light 
(originally all colorless solutions). The numbering corresponds to the entries in table S11. 
 
Table S12. Investigation of the H2O2 evolution in a MES-buffered solution of 1,3,5-trimethoxybenzene (1a) in the 
absence of photo-catalyst. 
Entry Vanadatea Substrate 1a MeCN c(H2O2) [mM] 
1 + + + 4.59 
2 + – + 0 
3 – + + 6.72 
4 + – – 0 
trimethoxybenzene (7.43 mM); no AmVHPO; overall volume 1.6 mL; irradiation for 16 h; avanadate 
(187.5 µM) and vanadate containing storage buffer (300 µL, 50 mM Tris pH 7.0, 100 µM Na3VO4)  
 
 
 
Figure S18. Color changes of the reaction mixtures; the numbering corresponds to the entries in table S12. A slight 
yellow discoloration is only observed for substrate-containing reaction mixtures (Entries 1 and 3). 
 
Table S13. Investigation of H2O2 evolution in 1,3,5-trimethoxybenzene (1a) solution in an absence of photocatalyst 
in phosphate buffer. 
 
Entry Light KBr (8.13 mM) Vanadate (187.5 µM) c(H2O2) [mM] 
1 455 nm + + 0 
2 – + + 0  
3 455 nm – + 0 
4 455 nm + – 5.19 
5 455 nm – – 6.19 
trimethoxybenzene (7.43 mM); no AmVHPO; overall volume 1.6 mL; O2 atmosphere; irradiation 
for 22 h. 
1 2 3 4 
1 3 4 5 
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4.10 Investigations on Decomposition of the Substrate by Photooxidation (C. J. Seel) 
Table S14. Photobiocatalytic bromination of N,N-dimethylaniline (1c) as a model reaction to investigate the 
impact of photooxidation on oxidation-sensitive substrates/products. 
 
Entry H2O2-source Conversion Ratio (o-2c : p-2c : o,p-di-2c) 
1 H2O2 (1.1 eq.)  99% 23 (o) : 71 (p) : 6 
2a FMN (30 mol%)/455 nm; (D) 99% 23 (o) : 43 (p) : 35 
3a FMN (30 mol%)/455 nm; (B) 99% 13 (o) : 70 (p) : 17 
4 FMN (30 mol%)/455 nm; (E) 1% 62 (o) : 38 (p) : 0 
5 FMN (30 mol%)/455 nm; (F) 2% 54 (o) : 46 (p) : 0 
6 FMN (30 mol%)/455 nm; (G) 98% 26 (o) : 63 (p) : 11 
  adecomposition of the substrate/product(s) was observed; AmVHPO (300 µL; 1.46 mg mL-1);  
   Methods B – G are described in chapter 4.2; conversions were determined by GC. 
 
Figure S19. GC chromatogram of the enzymatic N,N-dimethylanilin (1c) bromination using photochemical in situ 
H2O2 generation (30 mol% FMN, entry 3). Toluene was used as the internal standard. The formation of product o,o-
di-2c was not observed. The substrate is fully consumed, several peaks, which do not correspond to the products 
are observed indicating photochemical decomposition of the substrate/product(s) (labeled with an asterix).  
 
An additional example of photooxidation of the substrate is given below as comparative NMR spectra.
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FMN (0.5 mol%) AmVHPO 
FMN (0.5 mol%), no AmVHPO 
29 
 
4.11	Investigations	on	the	Buffer	Concentration	(C. J. Seel)	
In order to examine the influence of MES-buffer concentrations lower than 100 mM on the pH change of 
the reaction mixture and the conversions of the enzymatic bromination reaction, we performed a series 
of experiments using the electron-source in lower concentrations. The reactions were performed as 
described in chapter 4.2 (0.5 mol% FMN, 16 h irradiation, 1a as a substrate). 
 
 
Figure S20. Monitoring of the pH of the reaction mixtures (0.5 mol% FMN, summarized in Table S15). a) The pH was 
determined before irradiating the reaction mixture by the use of pH-indicator strips (MColorpHast™, pH 5.0 – 10.0, 
MerckMilipore). b) The pH was determined again after 16 h of irradiation (MColorpHast™, pH 5.0 – 10.0 and pH 0 – 
6.0, MerckMilipore). 
 
The pH was monitored prior to irradiation and after completion of the reaction and neither a significant 
pH change (Figure S20) nor an influence on the conversion (Table S15) of the substrate was observed for 
the reaction of 1a using of 25 – 100 mM MES as electron donor. 
 
Table S15. Influence of the buffer concentration on the photobiocatalytic bromination of 1,3,5-trimethoxybenzene 
(1a). 
 
 
 
Entry MES pH (start) pH (end) Conversion Ratio (2a : di-2a) 
1 25 mM 6.0 5.5 - 6.0 99% 92 : 8 
2 50 mM 6.0 6.0 99% 93 : 7 
3 100 mM 6.0 6.0 98% 95 : 5 
AmVHPO (2.28 mg mL-1; 300 µL)  
a) b) 
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5.	Flavin	Properties	(C. J. Seel, A. Králík)	
	
5.1 Degradation of the Enzyme by Excited FMN in High Catalyst Loadings (C. J. Seel) 	
											 													 	
 
Figure S21. Impact of photooxidation on the enzymes, the mixtures contained FMN (30 mol%). a) Reaction mixtures 
before irradiation, the VHPOs are soluble. b) Reaction mixtures after irradiation for 15 min; FMN (30 mol%) showing 
obvious precipitation of the enzymes. 
 
5.2 Self-Oxidation of FMN (A. Králík) 
When irradiated under inert nitrogen atmosphere in a non-oxidizable buffer without any other source of 
electrons, FMN is capable of self-oxidation forming a small portion of the reduced form of flavin, which 
can release hydrogen peroxide upon subsequent reoxidation with oxygen. This can be achieved by 
irradiation with green LEDs, because low absorbance of FMN in this region prevents quick photobleaching. 
A solution of FMN (2.25 mM) in phosphate buffer (10 mM, pH 6) was irradiated with 535 nm LEDs for 5.5 
hours in a sealed crimp-top vial under nitrogen atmosphere. Afterwards, oxygen was bubbled through the 
solution for 30 minutes and the concentration of hydrogen peroxide was measured using the POD assay. 
The resulting H2O2 concentration was 353 µM, which shows a decomposition of a majority of the 
photocatalyst. When this process was repeated with the same reaction mixture, no increase in H2O2 
concentration was observed. 
5.3 Absorption Spectra of FMN in Different Buffers (A. Králík) 
          
Figure S22. UV-Vis spectra of 10 µM FMN in different buffers at pH 6. a) Influence of different MES-concentrations 
on the absorbance. b) Shifted absorption maximum in citrate buffer. 
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Figure S22 illustrates that the absorption characteristics of FMN in citrate and MES buffer differ from other 
buffers at pH 6 or in water. Spectral differences can be explained by an interaction of ions with FMN in 
aqueous solutions.[11] The second absorption maximum at 370 nm could account for the protonated 
species of FMN.[12] This maximum is slightly blue-shifted in citrate buffer. 
 
6.	H2O2-Generation	by	Oxidative	Water	Splitting	Using	Au-TiO2	(A. Králík)	
6.1 Evaluation of Different Light Sources for H2O2 Generation via Water Oxidation (A. Králík) 
	
Figure S23. Activity of Au-TiO2 in terms of H2O2 production as a function of the wavelength. a) Short-term 
irradiation. The concentration of hydrogen peroxide was determined after 4 min of irradiation of an Au-TiO2 
(Degussa P25) suspension in pure water under oxygen atmosphere using different light sources. b) Long-term 
irradiation. The concentration of hydrogen peroxide was determined after 1 h of irradiation of an Au-TiO2 (pure 
rutile) suspension in pure water under oxygen atmosphere using different light sources. 
General Procedure 
A crimp-top vial (5 mL) equipped with a magnetic stirring bar containing a suspension of Au-TiO2 (pure 
rutile, 5 mg) in distilled water (1 mL) was sealed with a septum and the head-space atmosphere was 
exchanged with oxygen using a balloon. The vial was placed in a tempered (25 °C) aluminum block (see 
Section 4.2) and irradiated from the bottom with an LED of a specific wavelength (see Figure S23) for 1 h 
under slow stirring. Subsequently, the heterogeneous catalyst was removed via centrifugation, the 
supernatant was diluted 5-times with distilled water and the concentration of hydrogen peroxide was 
determined using the POD assay. 
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6.2 Kinetics of the H2O2 Evolution (A. Králík) 
 
Figure S24. Extended profile of H2O2 generation via irradiation (375 nm LEDs) of an Au-TiO2 suspension in water 
under oxygen atmosphere. 
Figure S24 shows an extended kinetic measurement of hydrogen-peroxide generation via water splitting 
with Au-TiO2. After reaching a maximal concentration of 800 µM within ca. 4 min, a first, short-term 
plateau around 600 µM is formed. After 30 min the concentration stabilizes at 400 µM forming a final, 
long-term plateau, which lasts for at least 5 h. In this case, a stable concentration represents an 
equilibrium between a photocatalytic formation of H2O2 and its quick decomposition in the presence of 
heterogeneous material.[13] Therefore, the drop in equilibrium concentration suggests a decrease in 
activity of Au-TiO2 during continuous irradiation. In addition, a color change can be observed, where the 
originally grey or slightly purple suspension turns pink after 1 hour of UV irradiation and completely white 
after 24 hours. This indicates that gold nanoparticles are released from the semiconductor surface and 
eventually decompose, which can explain the decrease in activity. The color change seems to be 
dependent on the amount of oxygen in the reaction mixture (see Figure S25). To prove the crucial role of 
gold nanoparticles in H2O2 generation, pure TiO2 (P25) was used instead of Au-TiO2 in the negative-control 
samples – no hydrogen peroxide was detected in those samples. 
    
Figure S25. Suspension of Au-TiO2 after 24 hours of 375 nm irradiation under different atmosphere: 1) before 
irradiation; 2) nitrogen; 3) air; 4) oxygen. 
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General Procedure 
A crimp-top vial (5 mL) equipped with a magnetic stirring bar containing a suspension of Au-TiO2 (pure 
rutile, 5 mg) in distilled water (1 mL) was sealed with a septum and the head-space atmosphere was 
exchanged with oxygen using a balloon. The vial was placed in a tempered (25 °C) aluminum block (see 
Section 4.2) and irradiated from the bottom with a 375 nm LED for a selected time under slow stirring. 
Subsequently, the heterogeneous catalyst was removed via centrifugation, the supernatant was diluted 
5-times with distilled water and the concentration of hydrogen peroxide was determined using the POD 
assay. 
Reaction under Inert Atmosphere 
A crimp-top vial (5 mL) equipped with a magnetic stirring bar containing a suspension of Au-TiO2 (pure 
rutile, 5 mg) in distilled water (1 mL) was sealed with a septum. The suspension was degassed by bubbling 
with nitrogen for 20 min and the head-space was evacuated and flushed with nitrogen five times. To 
confirm that no oxygen is present, the gas phase was analyzed with head-space GC prior to the irradiation. 
The vial was then placed in a tempered (25 °C) aluminum block (see Section 4.2) and irradiated from the 
bottom with a 375 nm LED for 1 h under slow stirring. Afterwards, the gas phase was analyzed again with 
head-space GC, the vial was unsealed, the heterogeneous catalyst was removed via centrifugation and 
the concentration of hydrogen peroxide in the supernatant was determined using the POD assay. 
No detectable oxygen was present in the gas phase after irradiation and H2O2 concentration in the 
reaction mixture was 0.89 µM. 
 
6.3 Comparison of the Activity of Different Forms of TiO2 (A. Králík) 
The rutile form of TiO2 has been chosen for photobiocatalytic experiments due to its recently described 
improved biocompatibility compared to the anatase form. The hydrophobic surface of rutile TiO2 prevents 
hydrophilic enzymes from adsorption and this spatial separation protects the enzyme from highly reactive 
— but short-lived — hydroxyl radicals formed by titanium dioxide in aerated aqueous solution upon 
irradiation.[13]  
A possible influence of the form of TiO2 — used as a precursor of the water-oxidation catalyst Au-TiO2 — 
on its activity in terms of H2O2 generation was investigated. For this purpose, results obtained with rutile-
based Au-TiO2 were compared to an Au-TiO2 catalyst prepared from Degussa P25 TiO2, which consists of 
75–85 % anatase.[14] Data presented in Figures S23, S26, and S27 show that the activity of both rutile- and 
P25-based catalysts rely on the same wavelength dependency, produce a comparable amount of 
hydrogen peroxide in one-point activity measurements, and have a similar kinetic profiles of H2O2 
generation. These results suggest that there is no difference in activity between anatase and rutile TiO2 in 
terms of photocatalytic generation of hydrogen peroxide via water oxidation in oxygenated aqueous 
solutions. 
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Figure S26. One-point-activity comparison between Au-TiO2 based on rutile, Degussa P25 TiO2 and a negative-
control experiment using pure Degussa P25 TiO2. The concentration of hydrogen peroxide was determined after 4 
min of irradiation (375 nm LEDs) of a catalyst suspension in pure water. 
 
Figure S27. Comparison of extended kinetic profiles of H2O2 generation between rutile- (red) and P25-based (black) 
Au-TiO2 catalysts via irradiation (375 nm LEDs) of a catalyst suspension in pure water under oxygen atmosphere. 
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6.4 Water-Splitting Coupled to AmVHPO Catalyzed Bromination (A. Králík) 
Control Reactions 
Table S16. Set of control reactions for bromination of 2,6-dimethoxypyridine (1e) using H2O2 generated via photo-
catalytic water splitting with Au-TiO2. 
	
Entry Light Au-TiO2 Atmosphere Enzyme Conversion Ratio (2e : di-2e) 
1 375 nm + O2 + 74 % (100 : 0) 
2 – + O2 + 0 % – 
3 375 nm – O2 + 0 % – 
4 375 nm + Air + 9 % (100 : 0) 
5 375 nm + N2 + 4 % (100 : 0) 
6 375 nm + O2 – 7 % (100 : 0) 
dimethoxypyridine (7.43 mM); AmVHPO (1.16 mg mL-1; 80 µL); KBr (8.13 mM); Na3VO4 (187.5 µM); overall 
volume 1.6 mL 
 
General Procedure 
Prior to the reaction, AmVHPO was transferred from the storage buffer (containing Good's buffers) to 
phosphate buffer (10 mM, pH 6) using a PD-10 Desalting column (GE Healthcare). Solutions of 1e (100 µL, 
118.9 mM in MeCN), Na3VO4 (10 µL, 30 mM in water), KBr (13 µL, 1 M in water), and AmVHPO (80 µL, 1.62 
mg mL-1 in 10 mM aqueous phosphate buffer pH 6) were added in a 5 mL crimp-top vial together with 
aqueous phosphate buffer (1.397 mL, 10 mM, pH 6). The vial was sealed with a rubber septum, its head-
space atmosphere was exchanged with oxygen using a balloon and it was placed into the irradiation setup 
(see Section 4.2) where it was irradiated with 375 nm LEDs at 25 °C for 24 h. Subsequently, the 
heterogeneous catalyst was removed via centrifugation and the supernatant was mixed with MeCN (800 
µL), brine (2 mL), and ethyl acetate (2 mL) and extracted. The organic phase was analyzed by HPLC. 
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7.	Synthesis	of	the	Halogenated	Reference	Material	(C. J. Seel)	
 
The synthesis of the brominated references 2a, di-2a, 3a, di-3a and o-2h, p-2h and di-2h has been 
reported previously.[3]  
 
7.1 General Procedure for the Synthesis of the Halogenated Products (C. J. Seel) 
 
N-Bromosuccinimide or N-chlorosuccinimide (1.1 eq. or 2.2 eq.) was added slowly to a cooled solution of 
the starting material (200 – 500 mg scale) in MeOH/dichloromethane (1/9; 10 mL). The resulting reaction 
mixture was stirred at 0°C for 2 h and the solvent was removed under reduced pressure. Subsequently, 
water (25 mL) was added and the mixture was extracted with EtOAc (3 × 25 mL). The combined organic 
phases were washed with brine, dried over MgSO4, filtered and the solvent was evaporated under reduced 
pressure. The crude mixture was purified by reversed phase chromatography on C18 silica (MPLC, 
H2O/MeCN gradient: 70/30 → 0/100 in 18 min). 
 
7.2 Synthesis of Ethyl 4-bromo-3,5-dimethyl-1H-pyrrole-2-carboxylate (2f) (C. J. Seel) 
 
N-Bromosuccinimide (1.05 eq.) was added slowly to a mixture of 3,5-dimethyl-1H-pyrrole-2-carboxylic 
acid ethyl ester (1 eq.) and potassium carbonate (1.05 eq.) in acetonitrile (0.85 M) cooled in an ice bath. 
The mixture was warmed to room temperature, diluted with water and then stirred for 30 min. The 
precipitate was collected by vacuum filtration, washed with ethanol/ water (1/2) and dried in vacuo.  
 
7.3 Up-Scaled Enzymatic Reaction on (E)-1,3-Dimethoxy-5-(4-methoxystyryl)benzene (1k) 
(C. J  Seel) 
 
The reaction mixture containing substrate (7.43 mM; 36.99 µmol), KBr (1.1 eq; 8.13 mM), MES pH 6.0 (50 
mM), Na3VO4 (187.5 µM), H2O2 (1.1 eq; 8.13 mM) and VHPO (1 mL; 4.5 mg mL-1; specific activity 39.51) in 
MeCN/H2O (1/1; total volume of 5.0 mL) was heated to 30°C and mixed at 300 rpm for 72 h. The reaction 
was stopped by addition of sat. NaCl solution and extraction with EtOAc (3 × 10 mL). The combined organic 
phases were washed with brine, dried over MgSO4, filtered and the solvent was evaporated under reduced 
pressure. The crude mixture was purified by semi-preparative HPLC controlled by a Jasco HPLC system 
consisting of an UV-1575 Intelligent UV/VIS Detector, two PU-2068 Intelligent prep. pumps, a M IKA 1000 
Dynamic Mixing Chamber (1000 μL Portmann Instruments AG Biel-Benken), a LC-NetII/ ADC), and a 
Rheodyne injection valve. The system was controlled by the Galaxie-Software. A Eurosphere II 100-5 C18 
A (KNAUER® 250 x 16 mm) column with pre-column (KNAUER® 30 x 16 mm) was used as the stationary 
phase (H2O (0.05% TFA)/MeCN (0.05% TFA) gradient: 95/5 → 0/100 in 43 min). The collected fractions 
were combined and the MeCN was removed under reduced pressure. The remaining aqueous phases 
were freeze-dried in liquid nitrogen and the water was removed by lyophilization (Alpha 2-4 Christ with 
Chemistry-Hybrid-Pump-RC6 pump).  
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Figure S28. Chromatogram of the preparative HPLC purification of the up-scaled enzymatic reaction. 
 
 
7.4 Preparation of (E)-2-Chloro-1,5-dimethoxy-3-(4-methoxystyryl)benzene (3d): (C. J. Seel) 
 
The reaction mixture containing (E)-1,3-Dimethoxy-5-(4-methoxystyryl)benzene (1k) (3.8 mg, 1.0 eq.) and 
N-chlorosuccinimide (1.9 mg, 1.0 eq.) in MeOH/dichloromethane (1/9; 1 mL) was stirred at 0°C for 2 h. 
Subsequently the solvent was removed under reduced pressure, water (10 mL) was added and the mixture 
was extracted with EtOAc (3 × 10 mL). The combined organic phases were washed with brine, dried over 
MgSO4, filtered and the solvent was evaporated under reduced pressure. The crude mixture was purified 
by semi-preparative HPLC as described in chapter 7.3. 
 
 
Figure S29. Chromatogram of the preparative HPLC purification of the chemical chlorination of 1k. 
 
 
2,4-Dibromo-N,N-dimethylaniline (o,p-di-2c):[15] yellowish oil; 1H NMR (500 MHz, CDCl3) δ = 
7.68 (d, J = 2.3 Hz, 1H), 7.36 (dd, J = 8.7, 2.3 Hz, 1H), 6.95 (d, J = 8.5 Hz, 1H), 2.78 (s, 6H) ppm; MS 
(EI, 70 eV): m/z (%) = 278 [M]+ (100), 276 [M]+ (54), 280 [M]+ (53), 263 (8), 198 (10), 118 (10). 
 
2-Br-2k 
6-Br-2k 
1k 3d 
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2-Bromo-3,4-dimethoxythiophene (2d):[16] greenish oil; 1H NMR (500 MHz, CDCl3) δ = 6.17 
(d, J = 21.8 Hz, 1H), 3.90 (d, J = 2.0 Hz, 3H), 3.84 (d, J = 21.1 Hz) ppm; MS (EI, 70 eV): m/z (%) 
= 224 [M]+ (100), 222 [M]+ (94), 209 [M-Me]+ (68), 207 [M-Me]+ (66). 
 
2,5-Dibromo-3,4-dimethoxythiophene (di-2d):[16] red oil; 1H NMR (500 MHz, CDCl3) δ = 3.91 
(s, 6H) ppm; MS (EI, 70 eV): m/z (%) = 304 [M]+ (52), 302 [M]+ (100), 300 [M]+ (52), 289 [M-
Me]+ (30), 287 [M-Me]+ (61), 285 [M-Me]+ (30).  
 
 
3-Bromo-2,6-dimethoxypyridine (2e):[17] yellowish oil; 1H NMR (500 MHz, CDCl3) δ = 7.64 
(d, J = 8.3 Hz, 1H), 6.23 (d, J = 8.3 Hz, 1H), 4.00 (s, 3H), 3.90 (s, 3H) ppm; MS (EI, 70 eV): m/z 
(%) = 219 (70) [M]+, 218 (96) [M]+, 217 (100) [M]+, 216 (65), 202 (17) [M-Me]+, 188 (57), 108 (22). 
 
3,5-Dibromo-2,6-dimethoxypyridine (di-2e):[18] white solid; 1H NMR (500 MHz, CDCl3) δ = 
7.86 (s, 1H), 3.99 (s, 6H) ppm; MS (EI, 70 eV): m/z (%) = 299 (46), 297 (100) [M]+, 295 (57), 
268 (45), 158 (23). 
 
Ethyl 4-bromo-3,5-dimethyl-1H-pyrrole-2-carboxylate (2f):[19] rose solid; 1H NMR (500 
MHz, CDCl3) δ = 9.02 (s br, 1H), 4.31 (q, J = 7.1 Hz, 2H), 2.28 (s, 3H), 2.26 (s, 3H), 1.36 (t, J 
= 7.1 Hz, 3H) ppm; MS (EI, 70 eV): m/z (%) = 247 [M]+ (70), 245 [M]+ (74), 218 [M-Et]+ (9), 
216 [M-Et]+ (10), 201 [M-Et-CO2]+ (100), 200 [M-Et-CO2]+ (95), 173 (18), 92 (44), 65 (38). 
 
3-Bromo-9H-carbazole (2g):[20] beige solid; 1H NMR (500 MHz, CDCl3) δ = 8.19 (d, J = 1.9 
Hz, 1H), 8.08 (s br, 1H), 8.03 (d, J = 7.8 Hz, 1H), 7.50 (dd, J = 8.6, 1.9 Hz, 1H), 7.47 – 7.42 
(m, 3H), 7.32 (d, J = 8.5 Hz, 1H), 7.25 (t, J = 7.9 Hz, 1H) ppm; MS (EI, 70 eV): m/z (%) = 245 
[M]+ (100), 246 [M]+ (17), 247 [M]+ (92), 248 [M]+ (13), 166 (50). 
 
3,6-Dibromo-9H-carbazole (di-2g):[20] beige solid; 1H NMR (500 MHz, CDCl3) δ = 8.13 
(d, J = 1.9 Hz, 2H), 8.11 (br s, 1H), 7.52 (dd, J = 8.6, 1.9 Hz, 2H), 7.31 (d, J = 8.6 Hz, 2H) 
ppm; MS (EI, 70 eV): m/z (%) = 327 [M]+ (54), 325 [M]+ (100), 323 [M]+ (55), 246 (22), 
164 (27). 
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4(5)-Bromo-2-phenyl-1H-imidazole (2i):[21] white solid; m. p. = 212°C; Rf = 0.69 (silica gel, 
pentane/EtOAc 50:50); 1H NMR (500 MHz, DMSO-d6) δ = 12.86 (s, 1H), 7.88 – 7.83 (m, 2H), 
7.42 (t, J = 8.4, 7.3 Hz, 2H), 7.38 (s, 1H), 7.34 (tt, J = 7.3 Hz, 1.2 Hz, 1H) ppm; 13C NMR (100 MHz, 
DMSO-d6) δ = 145.8, 129.6, 128.8, 128.5, 124.7, 117.3, 114.7 ppm; IR (film) !̃"#$ = 1500, 1456, 1398, 1122, 
777, 709, 670 cm-1; MS (EI, 70 eV): m/z (%) = 225 (13), 224 (96), 223 (7), 222(100) [M]+, 143 (79), 116 (83); 
HRMS (ESI) calcd. for C9H8BrN2 [M+H]+ 222.9871, found 222.9864. 
 
 4,5-dibromo-2-phenyl-1H-imidazole (di-2i):[22] beige solid; m. p. = 175°C (decomp.); Rf = 
0.71 (silica gel, pentane/EtOAc 50:50); 1H NMR (400 MHz, DMSO-d6) δ = 7.92 – 7.85 (m, 
2H), 7.50 – 7.43 (m, 2H), 7.42 – 7.36 (m, 1H) ppm; 13C NMR (100 MHz, DMSO-d6) δ = 146.9, 
129.0, 129.0, 128.9, 124.7 ppm; IR (film) !̃"#$ = 1502, 1457, 1398, 1004, 968, 768, 702, 685 cm-1; MS (EI, 
70 eV): m/z (%) = 304 (50), 302 (100), 300 (50) [M]+, 223 (38), 221 (42), 196 (38), 194 (42) ; HRMS (ESI) 
calcd. for C9H7Br2N2 [M+H]+ 300.8976, found 300.8969. 
 
3-Bromo-2-methyl-1H-indole (2j):[23] red solid; 1H NMR (500 MHz, CDCl3) δ = 7.99 (s br, 
1H), 7.51 – 7.44 (m, 1H), 7.31 – 7.22 (m, 1H), 7.22 – 7.09 (m, 2H), 2.44 (s, 3H) ppm; MS (EI, 
70 eV): m/z (%) = 211 [M]+ (100), 209 [M]+ (100), 130 [M-HBr]+ (100). 
 
 (E)-2-Bromo-1,5-dimethoxy-3-(4-methoxystyryl)benzene (2-Br-2k):[24] white 
solid; 1H NMR (500 MHz, CDCl3) δ = 7.50 (d, J = 8.7 Hz, 2H), 7.40 (d, J = 16.1 Hz, 
1H), 6.97 (d, J = 16.1 Hz, 1H), 6.91 (d, J = 8.7 Hz, 1H), 6.80 (d, J = 2.7 Hz, 1H), 6.42 
(d, J = 2.6 Hz, 1H), 3.89 (s, 3H), 3.87 (s, 3H), 3.84 (s, 3H) ppm; MS (ESI, positive): m/z = 349.0; 351.4 [M+H]+. 
 
 
 (E)-2-Bromo-1,3-dimethoxy-5-(4-methoxystyryl)benzene (6-Br-2k):[25] white 
solid; 1H NMR (500 MHz, CDCl3) δ = 7.46 (d, J = 8.7 Hz, 2H), 7.07 (d, J = 16.2 Hz, 
2H), 6.92 (d, J = 16.9 Hz, 1H), 6.91 (d, J = 8.5 Hz, 2H), 6.70 (s, 2H), 3.95 (s, 6H), 
3.84 (s, 3H) ppm; MS (ESI, positive): m/z = 349.0; 351.4 [M+H]+. 
 
2-Chloro-1,3,5-trimethoxybenzene (3a):[26] white solid; 1H NMR (500 MHz, CDCl3) δ = 
6.17 (s, 2H), 3.87 (s, 6H), 3.80 (s, 3H) ppm; MS (EI, 70 eV): m/z (%) = 202 [M]+ (100), 203 
[M]+ (13), 204 [M]+ (35), 205 [M]+ (4), 159 (35). 
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2,4-Dichloro-1,3,5-trimethoxybenzene (di-3a):[27] white solid; 1H NMR (500 MHz, CDCl3) δ 
= 6.38 (s, 1H), 3.91 (s, 6H), 3.89 (s, 3H) ppm; MS (EI, 70 eV): m/z (%) = 236 [M]+ (100), 
237 [M]+ (10), 238 [M]+ (69), 239 [M]+ (8), 240 [M]+ (13), 193 (50), 195 (33).  
 
1-Chloro-2,4-dimethoxybenzene (3b):[26] yellow oil; 1H NMR (300 MHz, CDCl3) δ = 7.29 (d, J 
= 1.0 Hz, 1H), 6.54 (d, J = 2.7 Hz, 1H), 6.46 (dd, J = 8.7, 2.7 Hz, 1H), 3.91 (s, 3H), 3.83 (s, 3H) 
ppm; MS (EI, 70 eV): m/z (%) = 172 [M]+ (100), 173 [M]+ (8), 174 [M]+ (31), 175 [M]+ (3), 129 
(50). 
 
(E)-2-Chloro-1,5-dimethoxy-3-(4-methoxystyryl)benzene (3d): white solid; m. 
p. = 85°C; 1H NMR (500 MHz, CDCl3) δ = 7.50 (d, J = 8.7 Hz, 2H), 7.41 (d, J = 16.2 
Hz, 1H), 7.26 (s, 3H), 7.01 (d, J = 16.2 Hz, 1H), 6.91 (d, J = 8.6 Hz, 2H), 6.80 (d, J 
= 2.6 Hz, 1H), 6.44 (s, 1H), 3.89 (s, 3H), 3.86 (s, 3H), 3.84 (s, 3H) ppm; 13C NMR 
(100 MHz, CDCl3) δ = 159.8, 158.8, 156.2, 137.3, 131.2, 129.9, 128.3, 123.1, 114.4, 114.3, 101.9, 99.0, 56.4, 
55.7, 55.5 ppm; IR (film) !̃"#$ = 1583, 1511, 1453, 1245, 1202, 1174, 1162, 1088, 1035, 827 cm-1; MS (ESI, 
positive): m/z = 305.1; 307.1 [M+H]+; HRMS (ESI) calcd. for C17H18ClO3 [M+H]+ 305.0944, found 305.0938. 
3-Chloro-1,2-dimethyl-1H-indole (3e): yellow solid; m. p. = 60°C; 1H NMR (500 MHz, 
CDCl3) δ = 7.56 (d, J = 7.8 Hz, 1H), 7.30 – 7.20 (m, 2H), 7.16 (t, J = 7.4 Hz, 1H), 3.69 (s, 3H), 
2.44 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ = 135.5, 132.4, 125.4, 121.8, 119.9, 117.6, 
109.0, 102.5, 30.1, 10.1 ppm; IR (film) !̃"#$ = 1705, 1470, 1323, 1238, 1172, 857, 728 cm-1; 
MS (EI, 70 eV): m/z (%) = 179 [M]+ (100), 181 [M]+ (33), 144 [M-HCl]+ (54); HRMS (ESI) calcd. for C10H11ClN 
[M+H]+ 180.0580, found 180.0574. 
 
 
 
The spectroscopic data are in agreement with those reported in the literature.  
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